Bio-AMD, Inc. products

The first stage of our corporate strategy has been to develop a universal digital strip reader (DSR).

Bio-AMD’s planned Generic PoC Magnetic Immunoassay Detection System (‘MIDS’), is expected to have a significantly enhanced sensitivity based on magnetic nano-particle manipulation and detection, capable of interpreting results on a quantitative basis.

Patented technology currently in commercial development with a global haematology partner.